pipette
ESEspañol

SIV reservoir depletion and clearance from neonatal macaques following transient CCR5 depletion

Jesse D. Deere, David Merriam, Kawthar Machmach, W. L. William Chang, Michael D. Nekorchuk, Gema Méndez‐Lagares, Hung T. Kieu, Joseph Dutra, Justin H. Fontaine, Denise R. Andal, Kateland Sipe, Elizabeth Heninger, Margaret Martin, Wenze Lu, Ning Chin, Connie Chen, Bryant Chi-Thien Tran, Jessica Salinas, Corey N. Miller, Steven G. Deeks, Jeffrey D. Lifson, Kathleen Engelman, Diogo M. Magnani, Keith A. Reimann, Mario Stevenson, Jacob D. Estes, Dennis J. Hartigan-O’Connor

Peer-reviewed journalClaims a big stepReal-world use

In the authors' words

Abstract Antiretroviral therapy (ART) suppresses viraemia in people with human immunodeficiency virus (HIV), but HIV provirus persists indefinitely in CD4-expressing cells. Cells containing active provirus express viral proteins and have been successfully targeted using broadly neutralizing antibodies (bnAbs). In contrast, cells containing latent provirus cannot be specifically targeted without latency reactivation. Meaningful depletion of the latent HIV or simian immunodeficiency virus (SIV) reservoirs has not been demonstrated except with cytotoxic conditioning for bone-marrow transplantation. Here we show that both the active and latent SIV reservoirs can be eliminated from infant macaques via profound but transient depletion of cells that express CCR5 using a single shot of CCR5/CD3 bispecific antibody. Neonatal rhesus macaques were infected with SIVmac251, then treated with ART beginning at 1 week after infection, followed by treatment with either a CCR5/CD3-bispecific or a CD4-specific antibody, both of which depleted target cells and accelerated the decline in plasma viraemia. Upon ART cessation, while rebound occurred quickly in all animals treated with ART alone, most animals treated with CCR5/CD3 bispecific antibody remained aviraemic for >3 months. Several remained aviraemic to the end of follow-up and efforts to detect replication-competent virus were unsuccessful. Our results show that bispecific antibody treatment achieves meaningful depletion of the replication-competent SIV reservoir and supports the possibility that clinically meaningful depletion of the HIV reservoir might be achievable for recently infected individuals.

Main resultLimitation the authors admit

In plain words AI summary

Antiretroviral therapy suppresses HIV in the blood, but the virus hides permanently in certain immune cells. Researchers gave infant macaques a single shot of a special antibody that temporarily removed cells with a surface marker called CCR5. Most treated animals stayed virus-free for over three months after stopping therapy. Some remained virus-free until the end of the study, and tests could not find any active virus. The authors suggest this approach might help deplete the HIV reservoir in recently infected people.

Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.

Appeared: Wednesday, October 21. Nature Microbiology. Peer-reviewed journal.

DOI: 10.1038/s41564-026-02511-3